Surprising Drug Combo May Slow Progression of Alzheimer’s Disease

Scientists are working around the clock to find ways to reduce the risk of or minimize symptoms of Alzheimer’s disease, which affects approximately 7 million people in the U.S. The numbers are expected to rise to 12.7 million by 2050.

A new study has found that the compounds in marijuana, THC, when combined with Celebrex (celecoxib), an anti-inflammatory drug commonly prescribed for arthritis and pain, may offer clues to further medical research. When combined, the treatment improved cognitive...